Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: a European organization for research and treatment of cancer randomized study with cross-over

R Paridaens; L Biganzoli; P Bruning; Jan Klijn; T Gamucci; SJ Houston; R Coleman; J Schachter; A van Vreckem; R Sylvester; A Awada; J Wildiers; MJ Piccart

Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: a European organization for research and treatment of cancer randomized study with cross-over

R Paridaens, L Biganzoli, P Bruning, Jan Klijn, T Gamucci, SJ Houston, R Coleman, J Schachter, A van Vreckem, R Sylvester, A Awada, J Wildiers, MJ Piccart

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

348 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	724-733
Number of pages	10
Journal	Journal of Clinical Oncology
Volume	18
Issue number	4
Publication status	Published - 2000

Research programs

EMC MM-03-86-01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Paridaens, R., Biganzoli, L., Bruning, P., Klijn, J., Gamucci, T., Houston, SJ., Coleman, R., Schachter, J., van Vreckem, A., Sylvester, R., Awada, A., Wildiers, J., & Piccart, MJ. (2000). Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: a European organization for research and treatment of cancer randomized study with cross-over. Journal of Clinical Oncology, 18(4), 724-733.

@article{33f940bbaa9341cdbe04372554828fc4,

title = "Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: a European organization for research and treatment of cancer randomized study with cross-over",

author = "R Paridaens and L Biganzoli and P Bruning and Jan Klijn and T Gamucci and SJ Houston and R Coleman and J Schachter and \{van Vreckem\}, A and R Sylvester and A Awada and J Wildiers and MJ Piccart",

year = "2000",

language = "Undefined/Unknown",

volume = "18",

pages = "724--733",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams \& Wilkins",

number = "4",

}

Paridaens, R, Biganzoli, L, Bruning, P, Klijn, J, Gamucci, T, Houston, SJ, Coleman, R, Schachter, J, van Vreckem, A, Sylvester, R, Awada, A, Wildiers, J & Piccart, MJ 2000, 'Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: a European organization for research and treatment of cancer randomized study with cross-over', Journal of Clinical Oncology, vol. 18, no. 4, pp. 724-733.

Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: a European organization for research and treatment of cancer randomized study with cross-over. / Paridaens, R; Biganzoli, L; Bruning, P et al.
In: Journal of Clinical Oncology, Vol. 18, No. 4, 2000, p. 724-733.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: a European organization for research and treatment of cancer randomized study with cross-over

AU - Paridaens, R

AU - Biganzoli, L

AU - Bruning, P

AU - Klijn, Jan

AU - Gamucci, T

AU - Houston, SJ

AU - Coleman, R

AU - Schachter, J

AU - van Vreckem, A

AU - Sylvester, R

AU - Awada, A

AU - Wildiers, J

AU - Piccart, MJ

PY - 2000

Y1 - 2000

M3 - Article

SN - 0732-183X

VL - 18

SP - 724

EP - 733

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 4

ER -